Within India's vast and growing diabetes crisis, a quieter condition hides in plain sight — Type 1.5 diabetes, an autoimmune disease that wears the mask of Type 2, affecting potentially millions who are being treated for the wrong illness. Unlike the lifestyle-driven form most associate with adult-onset diabetes, this condition arises from the immune system turning against itself, demanding insulin therapy that most patients never receive in time. It is a story of a disease that is not rare, only invisible — and of a healthcare system that has not yet learned to look for what it does not expec
The Times of India
· Jun 21, 2026
· health
· 3 min de leitura
High
Apuração: Verificado
Type 1.5 diabetes: India's hidden epidemic masquerading as Type 2
Millions of Indians with Type 1.5 diabetes face delayed insulin therapy and increased risk of long-term complications including vision loss, neuropathy, and poor blood sugar control due to misdiagnosis.
◉
Health & Medicine
8412 artigos relacionados
Retatrutide: Eli Lilly's Triple-Action Weight-Loss Drug Poised to Resh…
The Economic Times · 100% correspondência
Eli Lilly Seeks FDA Approval for Tirzepatide as Weight-Loss Treatment
Interesting Engineering · 99% correspondência
Eli Lilly's Oral GLP-1 Pill Shows Promise for Diabetes and Weight Loss
TODAY · 99% correspondência
Eli Lilly Seeks FDA Approval for Tirzepatide as Weight Loss Drug
ScienceAlert · 99% correspondência
Moderna's personalized mRNA melanoma vaccine shows promise in preventi…
CBS News · 99% correspondência
Cobertura Relacionada
BBC News · Aug 25
School asbestos exposure linked to woman's death at 46, family claims
A woman died from mesothelioma at 46, likely exposed to asbestos at her Cardiff school decades earlier. Her family is su…
Future of Personal Health - · Aug 25 NGS Technology Transforms Uncertain Infections Into Actionable DiagnosesHybrid-capture NGS technology helps clinicians identify pathogens in diagnostically challenging cases by simultaneously …
The Guardian · Aug 25 Shark attack survivor Leah Stewart recalls 'monster' in first interview since losing armLeah Stewart, who lost her arm in a June shark attack at Coogee Beach, recalls the traumatic encounter in her first inte…
Education News Canada · Aug 25 Systemic racism, restrictive policies block Black Canadians from blood donationBlack Canadians face systemic barriers to blood donation despite critical need for ethnicity-matched blood for sickle ce…
Impacto Geopolítico
🌎
Type 1.5 diabetes (LADA) affects 5-12% of India's 89.8 million diabetics but remains largely undiagnosed due to misclassification as Type 2, with no direct geopolitical implications.
Escalation Risk
low
Confidence
HIGH
Viés e Enquadramento
⚖
Article uses urgent language ('hidden epidemic,' 'stubborn problem') to raise awareness of underdiagnosed Type 1.5 diabetes, presenting medical information with advocacy-oriented framing.
Bias Direction
center-left
Confidence
MED
Problem-solution narrative with medical urgency. Uses metaphors of concealment ('buried,' 'hidden,' 'quieter') to frame Type 1.5 diabetes as an overlooked public health crisis requiring attention. Emphasizes gaps in medical knowledge and diagnosis.
hidden epidemic
quieter, more stubborn problem
the body turns on itself
uncomfortable reading
precisely why it's so often mistaken
misdiagnosis and delay
Perspective from general practitioners or primary care doctors on diagnostic challenges and resource constraints
Patient testimonials or lived experiences with delayed diagnosis
Healthcare system/policy perspective on screening infrastructure
Epidemiological data on actual misdiagnosis rates in India specifically
Counterargument or nuance on whether increased screening would be cost-effective
Perspective from diabetes organizations on current awareness efforts
Lente Econômica
📈
Type 1.5 diabetes (LADA) affects 5-12% of India's 89.8 million diabetics but remains largely undiagnosed, creating hidden healthcare costs and economic burden through delayed treatment and preventable complications.
Market Signal
bearish
Confidence
MED
Healthcare and pharmaceuticals
Medical diagnostics and testing
Insurance and health coverage
Pharmaceutical manufacturing
Hospital and clinical services
Workforce productivity and absenteeism
Households face higher out-of-pocket medical expenses due to delayed diagnosis, preventable complications, and eventual insulin dependency. Misdiagnosis leads to ineffective Type 2 treatments, increasing overall healthcare costs. Affected individuals experience reduced productivity and earning capacity.
Government should mandate LADA screening protocols in diabetes diagnosis, invest in medical education for better disease recognition, expand insulin subsidy programs, and strengthen diagnostic infrastructure. Health insurance policies may need revision to cover autoimmune diabetes management. Public health campaigns required to raise awareness among patients and practitioners.